Berkman Charles S 4
4 · OmniAb, Inc. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
OmniAb (OABI) CLO Charles Berkman Sells Shares, Receives Awards
What Happened
Charles S. Berkman, Chief Legal Officer of OmniAb, reported multiple equity events on 2026-02-18. The filing shows derivative conversions/exercises (code M) that resulted in acquisitions of 18,750 shares (reported at $0.00 exercise price), two RSU grants/awards (60,000 and 600,000 RSUs) and a sell-to-cover sale of 9,673 shares in the open market at a weighted average price of $1.71 for proceeds of $16,541. The sale was required to satisfy tax-withholding obligations related to RSU vesting and is not a discretionary sale.
Key Details
- Transaction date: 2026-02-18; filing date: 2026-02-18 (same-day filing).
- Sales: 9,673 shares sold in multiple transactions at a weighted average price of $1.71 (range $1.68–$1.73), total proceeds ~$16,541 (footnote F4).
- Acquisitions: report shows exercises/conversions of derivatives (18,750 shares acquired at $0.00) and grants/awards of 60,000 and 600,000 RSUs (reported at $0.00) (codes M and A).
- Tax withholding: the sale of 9,673 shares was a mandated "sell-to-cover" to satisfy tax-withholding on RSU vesting (footnote F3).
- RSU details: each RSU represents the right to one share (F2); one RSU grant vests in three substantially equal annual installments beginning Feb 18, 2026 (F1), another RSU grant vests in three substantially equal annual installments beginning Feb 18, 2027 (F5).
- Option vesting: a separate stock option grant vests 12.5% after 6 months, then in 42 monthly installments (F6).
- Shares owned after transaction: not specified in the information provided in your summary.
Context: The filing shows predominantly non-discretionary equity activity (awards/vesting and derivative conversion) with a routine sell-to-cover for taxes. Purchases here are awards/vests (not open-market buys), which are common compensation events; the only market sale was to cover withholding and does not necessarily indicate a change in insider sentiment.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1][F2]2026-02-18+18,750→ 402,373 total - Sale
Common Stock
[F3][F4]2026-02-18$1.71/sh−9,673$16,541→ 392,700 total - Exercise/Conversion
Restricted Stock Units
[F2][F1]2026-02-18−18,750→ 64,584 totalExercise: $0.00→ Common Stock (18,750 underlying) - Award
Restricted Stock Units
[F2][F5]2026-02-18+60,000→ 124,584 totalExercise: $0.00→ Common Stock (60,000 underlying) - Award
Stock Option
[F6]2026-02-18+600,000→ 600,000 totalExercise: $1.71Exp: 2036-02-18→ Common Stock (600,000 underlying)
Footnotes (6)
- [F1]Represents the vesting of an RSU grant which occurs in three substantially equal annual installments beginning on February 18, 2026.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock
- [F3]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and do not represent discretionary trades by the reporting person.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.68 to $1.73. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The RSU grant vests in three substantially equal annual installments beginning on February 18, 2027.
- [F6]The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.